| Detected | Trial | Change |
|---|---|---|
| 2026-06-11 | NCT07377981 Efficacy and Safety of Esketamine Combined With Dexmedetomidine in Non-Invasive ICU… |
Primary endpoint(s) modified |
| 2026-05-30 | NCT07377981 Efficacy and Safety of Esketamine Combined With Dexmedetomidine in Non-Invasive ICU… |
Primary endpoint(s) modified |
| 2026-05-30 | NCT07377981 Efficacy and Safety of Esketamine Combined With Dexmedetomidine in Non-Invasive ICU… |
Enrollment increased: 132 -> 388 participants |
| 2026-05-16 | NCT07394387 Neoadjuvant Study of HIFU With or Without PD-1 Inhibitors Followed by Abraxane Plus… |
Enrollment increased: 39 -> 58 participants |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-11 | NCT07641114 Behavior Change Wheel-Based Music Listening for Chemotherapy-Related Cognitive Impairment… | Completed | |
| 2026-06-05 | NCT07628582 A Study of the LVIVO-TaVec122 Product in Subjects With Relapsed/Refractory B-cell… | Phase 1 | Not Yet Recruiting |
| 2026-06-05 | NCT07628595 Safety and Efficacy of RN9101 in the Treatment of Relapsed/Refractory Multiple Myeloma | Early Phase 1 | Not Yet Recruiting |
| 2026-06-03 | NCT07622836 A Prospective, Multicenter, Phase II Clinical Study of Postoperative Chemotherapy… | Recruiting | |
| 2026-05-29 | NCT07612670 A Prospective Cohort Study on the Epidemiological Investigation, Diagnosis, and Treatment… | Not Yet Recruiting | |
| 2026-05-27 | NCT07608978 Efficacy and Safety of Polatuzumab Vedotin in Combination With Zanubrutinib, Rituximab… | Phase 2 | Recruiting |
| 2026-05-26 | NCT07606820 Real-World Study of Cligabalin(HSK16149) for the Treatment of Neurogenic Rosacea | Enrolling by Invitation | |
| 2026-05-15 | NCT07589699 Trastuzumab Rezetecan (T-DXh) in HER2+ Breast Cancer With Non-pCR After TCbHP | Phase 4 | Not Yet Recruiting |
| 2026-05-14 | NCT07587983 Real-World Treatment of ADC-Resistant HER2-Low Advanced Breast Cancer | Completed |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07232095 | 7-Day Vonoprazan, High-Dose Amoxicillin, and Bismuth Therapy | Helicobacter Pylori | Recruiting |
| NCT07558863 | Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes | Type 2 Diabetes | Recruiting |
| NCT07589699 | Trastuzumab Rezetecan (T-DXh) in HER2+ Breast Cancer With Non-pCR After TCbHP | Breast Cancer | Not Yet Recruiting |
| NCT07377981 | Efficacy and Safety of Esketamine Combined With Dexmedetomidine in Non-Invasive ICU… | Dexmedetomidine | Not Yet Recruiting |
| Phase 3 | |||
| NCT06759636 | A Study on the Treatment of CTIT of the Efficacy and Safety With Romiplostim N01 Compared… | CTIT: Cancer Therapy Induced Thrombocytopenia | Recruiting |
| NCT07331454 | Robotic vs Laparoscopic Gastrectomy for cT4a Gastric Cancer | Gastric Cancer (GC) | Not Yet Recruiting |
| Phase 2 | |||
| NCT07396454 | Study on the Treatment of HER2-negative Breast Cancer Brain Metastases With Radiotherapy… | HER2-Negative Breast Cancer | Recruiting |
| NCT07410520 | PD-1 Inhibitor Combined With Rituximab, Methotrexate, and Orelabrutinib (PD-1i+RMO) for… | Primary Central Nervous System Lymphoma (PCNSL) | Recruiting |
| NCT07418190 | Efficacy and Safety of Zanubrutinib, Rituximab, and Lenalidomide (ZR²) in Combination… | Relapsed/Refractory Follicular Lymphoma | Recruiting |
| NCT07446452 | Disitamab Vedotin Plus Bevacizumab in HER2-Low Metastatic Breast Cancer After T-DXd… | HER2-low Breast Cancer | Recruiting |
| NCT07448324 | Orelabrutinib Combined With Rituximab ± Lenalidomide in Response-Adapted Stratified… | Marginal Zone Lymphoma(MZL) | Recruiting |
| NCT07455019 | A Study of Bemosubaiabimab Combined With Anlotinib and Radiotherapy and Chemotherapy for… | Esophageal Cancer | Recruiting |
| NCT07474324 | Disitamab Vedotin Combined With SOX Regimen Versus SOX Alone as Adjuvant Therapy for… | GC/GEJC | Recruiting |
| NCT07277439 | Phase II Trial of Neoadjuvant Thymalfasin, PD-1 Inhibitor, and Chemoradiotherapy for… | Gastric Cancer | Recruiting |
| NCT07394387 | Neoadjuvant Study of HIFU With or Without PD-1 Inhibitors Followed by Abraxane Plus… | Triple Negative Breast Cancer (TNBC) | Recruiting |
| NCT07438106 | A Phase II Study of HRS-4642 Combined With AG (Nab-paclitaxel and Gemcitabine) as… | Locally Advanced Pancreatic Cancer With KRAS G12D Mutation | Recruiting |
| NCT07608978 | Efficacy and Safety of Polatuzumab Vedotin in Combination With Zanubrutinib, Rituximab… | Diffuse Large B-Cell Lymphoma (DLBCL) | Recruiting |
| NCT06577194 | A Single-Center, Single-Arm Study of Neoadjuvant Short-Course Radiotherapy Followed by… | Rectal Cancer | Recruiting |
| NCT07315035 | QL1706-SOX vs SOX Alone as Neoadjuvant Therapy for Resectable Diffuse-Type Gastric Cancer | Gastric Cancer Stage III | Not Yet Recruiting |
| NCT07347288 | SHR2554 as Maintenance Therapy in Patients With Peripheral T-cell Lymphoma | PTCL | Not Yet Recruiting |
| NCT07391826 | Megestrol Acetate Oral Suspension for Cachexia in Patients With cStage III… | Stage III Gastric Cancer | Not Yet Recruiting |
| NCT07400315 | First-line Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma With Dual… | Gastric or Gastroesophageal Junction Adenocarcinoma | Not Yet Recruiting |
| NCT07464756 | SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy… | Gastric Adenocarcinoma | Not Yet Recruiting |
| NCT07471165 | A Prospective, Single-Arm, Phase II Study: PD-L1 Monoclonal Antibody + Chemoradiotherapy… | Locally Advanced Perihilar Cholangiocarcinoma | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT07418177 | Study in Human iPSCs-derived RPE Cells Transplantation for Late-Stage AMD | AMD - Age-Related Macular Degeneration | Not Yet Recruiting |